Disc Stack Centrifuges in the Production of Monoclonal Antibody

Monoclonal Antibodies (mAbs) have become one of the most important classes of biopharmaceutical products, playing a critical role in the treatment of cancer, autoimmune diseases, infectious diseases, and rare disorders.

As global demand for antibody therapeutics continues to grow, manufacturers are under increasing pressure to improve productivity, maintain product quality, and comply with stringent GMP regulations.

One of the most critical stages in monoclonal antibody manufacturing is downstream processing, where cell culture broth must be efficiently clarified before purification.

Disc stack centrifuges have emerged as a preferred technology for large-scale cell harvesting and clarification due to their high throughput, gentle product handling, and fully enclosed sterile design.

What Are Monoclonal Antibodies?

Monoclonal antibodies are a group of antibodies produced by a single B cell clone. They are large molecules comprising multiple parts. Due to the complexity of their preparation, monoclonal antibodies are difficult to produce rapidly and on a large scale, especially compared to other types of therapies such as oral medications or vaccines.

What Are the Traditional Methods for Producing Monoclonal Antibodies (mAbs)?

Traditional monoclonal antibody (mAb) production protocols typically begin with the construction of mAb-producing cells, achieved by fusing myeloma cells with spleen cells that produce the target antibody. These B cells are almost entirely derived from animals, specifically mice. After the two cell lines are fused, a large number of clones are screened and selected based on the immunoglobulin class and antigen specificity of each clone.

Each “hit” or promising candidate hybridoma cell line undergoes additional testing for validation, confirmation, and characterization. Once completed, the clones are scaled up for use in further downstream bioprocesses.

The Downstream Clarification Challenge in mAb Production

Most monoclonal antibodies are produced using Chinese Hamster Ovary (CHO) cells or other mammalian cell culture systems.

Before Protein A chromatography and subsequent purification steps, these impurities must be removed efficiently without damaging sensitive biomolecules.

Disc stack centrifuges provide an effective alternative by continuously separating cells and solids from the liquid phase using high centrifugal forces.

Application of Disc Stack Centrifuges in Cell Harvesting

Industrial disc stack separators represent the standard technology for primary clarification in large-scale mAb workflows. By utilizing high centrifugal force fields, these systems achieve continuous mechanical separation of solids from liquid phases based on density differentials.

The clarification efficiency is governed by Stokes’ Law, where the settling velocity of cellular particles is amplified by the centrifugal acceleration factor:
v_c =

d²(ρ_p – ρ_f)ω²r
18μ


d – particle diameter
(ρ_p-ρ_f)- density delta between the cell and the media
ω – angular velocity
μ- fluid viscosity

The closely spaced conical discs reduce the settling distance, drastically accelerating sediment deposition down to sub-micron levels (0.5 µm).

1. Gentle Hydrodynamic Design to Minimize Cell Lysis.

To prevent shear-induced cell lysis, pharmaceutical-grade separators utilise specialised hydro-hermetic or fully hermetic inlet systems. By accelerating the incoming cell broth smoothly from a standstill to the rotational speed of the bowl, these designs keep shear stress below critical thresholds, limiting the release of intracellular contaminants and ensuring a cleaner centrate.

2. High G-Force and Configurable Solid Discharge.

Equipped with high G-force capabilities, disc stack separators effectively pelletize both whole cells and sub-micron cellular debris. Automatic timed partial or full solid ejections ensure consistent sludge dryness, minimizing liquid loss while maintaining continuous, uninterrupted operation.

Why Disc Stack Centrifuges Are Ideal for mAb Production?

A disc stack centrifuge uses a series of conical discs inside a rapidly rotating bowl to create a large settling area. This design dramatically increases separation efficiency while maintaining continuous operation.

For monoclonal antibody production, the technology offers several advantages:

High Clarification Efficiency

The disc stack design provides excellent removal of mammalian cells and cell fragments from fermentation broth. By reducing turbidity before filtration and chromatography, manufacturers can improve downstream process performance and reduce filtration burden.

Gentle Cell Handling

Mammalian cells are highly shear-sensitive. Excessive mechanical stress can lead to cell lysis, releasing host cell proteins, DNA, and other contaminants into the product stream.

Modern pharmaceutical disc stack centrifuges utilize hydro-hermetic feed systems and controlled acceleration zones to minimize shear forces and protect product quality.

Continuous Processing Capability

Unlike batch separation technologies, disc stack centrifuges operate continuously, making them suitable for both traditional fed-batch and intensified bioprocessing platforms.

Huading Separator Solutions for Pharmaceutical Manufacturing

Engineered to meet the most demanding sanitary and operational criteria of US FDA, EMA, and cGMP guidelines, Huading Separator provides dedicated disc stack centrifuges optimized for pharmaceutical and bioprocess applications. Specifically, the BTSX-M series in steam-sterilizable design provides an ideal match for high-value mAb harvesting, vaccine separation, and blood plasma separation.

Integration into the Complete Purification Pipeline

Implementing a high-efficiency disc stack centrifuge as the primary clarification step alters the downstream profile favorably. In the disk stack centrifuge, the suspension is separated into solids and clarified liquid continuously. By removing bulk biomass and cell fragments under sterile conditions, the centrifuge dramatically reduces the solid particle load directed onto secondary depth filters and sterile membrane filtration stages.

After sterilization, the separator is blanketed with sterile air (which also cools down the machine), ensuring a seamless transition to the next product run. This protection extends the operating life of expensive downstream filtration matrices and enhances the binding efficiency of subsequent Protein A affinity chromatography columns.

The Future of mAb Downstream Processing

As monoclonal antibody production continues moving toward higher cell densities, continuous bioprocessing, and intensified manufacturing, efficient cell harvesting technologies will become increasingly important.

Disc stack centrifuges provide the combination of scalability, sterility, automation, and separation performance required by next-generation biopharmaceutical facilities. By integrating advanced separator technology into downstream operations, manufacturers can reduce process bottlenecks, improve product recovery, and maintain the high quality standards demanded by global regulatory authorities.

Why Partner with Huading Separator for mAb Production?

With pharmaceutical-grade features such as CIP/SIP sterilization, hermetic containment, foam-free discharge, and automated process control, the Huading BTSX-M Disc Stack Separator provides an effective solution for modern monoclonal antibody production facilities seeking greater efficiency, product quality, and regulatory compliance.

Get A Quote